Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

Egypt flag Egypt · Delayed Price · Currency is EGP
878.53
-0.66 (-0.08%)
At close: Apr 27, 2026
111.13%
Market Cap 4.39B
Revenue (ttm) 3.02B
Net Income (ttm) 494.04M
Shares Out 5.00M
EPS (ttm) 98.81
PE Ratio 8.89
Forward PE n/a
Dividend 62.95 (7.17%)
Ex-Dividend Date Nov 4, 2025
Volume 712
Average Volume 3,061
Open 879.19
Previous Close 879.19
Day's Range 874.00 - 882.00
52-Week Range 400.02 - 1,000.96
Beta -0.07
RSI 71.19
Earnings Date May 14, 2026

About EGX:AXPH

Alexandria Co. For Pharmaceuticals & Chemical Industries operates as a pharmaceutical company in Egypt. The company manufactures, markets, and distributes branded generics of human and animal health products. It also provides human products, such as tablets, syrups, suppositories, drops, ampoule, and crème; medical appliances; and Veterinary Products. In addition, the company offers antibiotics and anesthetics, ophthalmic, cardiovascular, gastrointestinal, genitourinary, and respiratory drugs. Alexandria Co. For Pharmaceuticals & Chemical Indus... [Read more]

Industry Pharmaceutical Preparations
Founded 1962
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol AXPH
Full Company Profile

Financial Performance

In fiscal year 2025, EGX:AXPH's revenue was 2.75 billion, an increase of 55.56% compared to the previous year's 1.77 billion. Earnings were 391.17 million, an increase of 80.53%.

Financial Statements

News

There is no news available yet.